Orthofix Medical Inc.
OFIX
$14.51
$0.010.07%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 4.84% | 5.85% | 7.08% | 17.32% | 28.94% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.84% | 5.85% | 7.08% | 17.32% | 28.94% |
| Cost of Revenue | 5.97% | 4.56% | -1.09% | 6.05% | 25.65% |
| Gross Profit | 4.31% | 6.48% | 11.28% | 23.22% | 30.55% |
| SG&A Expenses | 3.04% | 2.76% | 0.40% | 9.41% | 19.44% |
| Depreciation & Amortization | -19.27% | -18.31% | 13.28% | 28.19% | 34.89% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.73% | 2.26% | -0.56% | 7.85% | 20.62% |
| Operating Income | 15.50% | 23.58% | 42.86% | 39.41% | 22.51% |
| Income Before Tax | -4.02% | -14.02% | 16.68% | 13.02% | -2.93% |
| Income Tax Expenses | -60.27% | -24.49% | -21.87% | 5.44% | -28.43% |
| Earnings from Continuing Operations | -2.67% | -13.12% | 16.78% | 12.66% | -1.99% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.67% | -13.12% | 16.78% | 12.66% | -1.99% |
| EBIT | 15.50% | 23.58% | 42.86% | 39.41% | 22.51% |
| EBITDA | 184.12% | 134.01% | 98.59% | 81.12% | 62.19% |
| EPS Basic | 0.85% | -8.92% | 20.46% | 19.53% | 12.50% |
| Normalized Basic EPS | 8.93% | 5.14% | 22.51% | 28.99% | 19.76% |
| EPS Diluted | 0.75% | -8.94% | 20.54% | 19.61% | 12.60% |
| Normalized Diluted EPS | 8.93% | 5.14% | 22.51% | 28.99% | 19.76% |
| Average Basic Shares Outstanding | 3.70% | 3.59% | 4.02% | 16.63% | 33.27% |
| Average Diluted Shares Outstanding | 3.70% | 3.59% | 4.02% | 16.63% | 33.27% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |